TSX closed
Loading markets…

Advertisement

Stocks

Why Curaleaf Holdings Inc. stock is sliding today

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:CURA.TO

Follow CURA

Photos provided by Pexels

Curaleaf's recent performance raises concerns among investors as the stock faces a notable decline.

Curaleaf Holdings Inc. (CURA.TO) is experiencing a downturn in its stock value, sliding by 3.57% in today's session. This decline comes despite the company's recent inclusion in the FTSE Canada All Cap Index, which usually signals positive momentum for stocks. However, investors are questioning whether Curaleaf can sustain its growth amid increasing competition and market volatility.

Advertisement

Curaleaf Holdings Inc.

CURA.TO

Full stock page →

CURA.TO

Curaleaf Holdings Inc.

Source:WealthAwesomeWealthAwesome
↑ $6.72 (66.67%)
120 day period
$9.39$13.10$16.80Apr 2Jun 29Sep 23

Market cap

$4.45B

52W high

$20.93

52W low

$7.77

1W change

+19.91%

Beta

1.64

Analyst Price Targets

Based on analyst covering CURA · as of Sep 24, 2026

📈

Wall Street analysts forecast CURA stock price to rise 11.6% over the next 12 months.

Consensus

Moderately Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$18.74

+11.6% Upside

Previously C$18.71 on Sep 23, 2026

Current Price

C$16.80

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CURA's historical volatility

HistoricalForecast68%95%
C$10.36C$16.07C$21.77C$27.48C$33.18C$38.89TodayMay 15Jul 21Sep 23Nov 5Dec 19Jan 31

30-Day Vol

52.8%

Annualized

90-Day Vol

61.0%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$20.08

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$17.83C$14.86 – C$21.39
60 trading daysC$18.92C$14.63 – C$24.49
90 trading daysC$20.08C$14.65 – C$27.54

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: While Curaleaf's addition to major indices could attract institutional investors, the current drop in stock price highlights the challenges it faces in a competitive cannabis market.

Curaleaf's stock down 3.57% today

Despite being added to the FTSE Canada All Cap Index, Curaleaf's stock has seen a significant decline, indicating market skepticism about its future performance.

Bull case

Curaleaf's recent inclusion in the FTSE Canada All Cap Index could boost its visibility and draw in institutional investors. This might lead to a recovery in the stock price as more people become aware of the company.

Bear case

The 3.57% drop today reflects ongoing concerns about Curaleaf's profitability and market position, especially as competition heats up in the cannabis sector. Investors may continue to be cautious as the company navigates these challenges.

Advertisement

Market Reaction to Curaleaf's Performance

Curaleaf's stock performance today reflects broader sentiment within the cannabis sector, which has seen fluctuations as companies deal with regulatory changes and competitive pressures. The 3.57% decline in CURA.TO raises questions about investor confidence, particularly following its recent index inclusion. While this move was expected to enhance liquidity and visibility, the immediate market reaction suggests that investors are weighing potential risks against the backdrop of a challenging industry landscape.

Implications of Index Inclusion

Being added to the FTSE Canada All Cap Index is often seen as a positive sign for a company's growth prospects, as it can attract new institutional investors. However, Curaleaf's current stock slide indicates that such inclusion alone may not be enough to stabilize its market performance. Investors should keep an eye on how Curaleaf leverages this opportunity to improve its operational efficiency and address profitability concerns, especially in a sector known for its volatility.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 24, 2026
Last Updated: September 24, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement